Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs
Open Access
- 25 September 2020
- journal article
- research article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 22 (11) , 1-8
Abstract
Purpose of Review Adipocytes have recently been shown to be able to reprogram to a myofibroblastic phenotype in a process termed adipocyte mesenchymal transition (AMT). This review seeks to discuss the relevance of this process to disease and explore its mechanisms. Recent Findings AMT occurs in multiple organs and diseases, transdifferentiation goes through a precursor cell and there is a reversible process that can be influenced by metabolic stress, myeloid cells, immune dysregulation, and pharmacological intervention. Summary AMT is a newly appreciated and highly relevant process in multiple forms of fibrosis. Targeting AMT may serve as a novel method of treating fibrosis.Keywords
This publication has 44 references indexed in Scilit:
- Myofibroblasts in Murine Cutaneous Fibrosis Originate From Adiponectin‐Positive Intradermal ProgenitorsArthritis & Rheumatology, 2014
- Fibroblasts in fibrosis: novel roles and mediatorsFrontiers in Pharmacology, 2014
- Defining dermal adipose tissueExperimental Dermatology, 2014
- Distinct fibroblast lineages determine dermal architecture in skin development and repairNature, 2013
- Fibrosis and Adipose Tissue DysfunctionCell Metabolism, 2013
- Intradermal adipocytes mediate fibroblast recruitment during skin wound healingDevelopment, 2013
- Changing paradigms in spondylarthritis: The myofibroblast signatureArthritis & Rheumatism, 2012
- Adipocyte Lineage Cells Contribute to the Skin Stem Cell Niche to Drive Hair CyclingCell, 2011
- Unraveling the Molecular Pathophysiology of Myelodysplastic SyndromesJournal of Clinical Oncology, 2011
- Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VIMolecular and Cellular Biology, 2009